Media formats available:
Recommended
- AHA 2018Unexpectedly large CV benefit with icosapent ethyl in statin-treated patients at high CV risk
Prof. Erik Stroes, MD
Dorairaj Prabhakaran, MD
Eric Velazquez, MD
Prof. Erik Stroes, MD
Dorairaj Prabhakaran, MD
Eric Velazquez, MD